December 7, 2017, SAN ANTONIO – StemBioSys Inc. announced that it has entered into an agreement with Caltag Medsystems Ltd. to distribute and market StemBioSys products. Caltag will distribute StemBioSys products in the European Union. [Read more…]

SAN ANTONIO – StemBioSys Inc. announced today that it will add a second office location. StemBioSys’s new location in Houston will be located in Johnson & Johnson Innovation, JLABS (JLABS) at the Texas Medical Center (JLABS @ TMC). JLABS is a life science innovation center, providing a flexible environment for start-up companies pursuing new technologies and research platforms to advance medical care. Through a “no strings attached” model, Johnson & Johnson Innovation does not take an equity stake in the companies occupying JLABS and the companies are free to develop products -either on their own, or by initiating a separate external partnership with JJI or any other company.

StemBioSys President & CEO, Bob Hutchens stated, “We are pleased to be a resident company at JLABS @ TMC and look forward to taking full advantage of the opportunity to be part of the biotech community in Houston through our virtual presence at JLABS.” Hutchens also noted that the primary location for the company would remain in San Antonio. “We are committed to the San Antonio community. All of our employees will remain based in San Antonio. There are a number of advantages we enjoy because of our San Antonio location.” [Read more…]